Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
Source:
Nasdaq GlobeNewswire
/
11 Jan 2024 08:00:00 America/New_York
N/A
Share on,